✦ LIBER ✦

644 OPTIMAL LENGTH OF ANTIVIRAL THERAPY IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 2 AND 3: A META-ANALYSIS

✍ Scribed by S. Slavenburg; I. Weggelaar; M.G.H. van Oijen; J.P.H. Drenth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal therapy in hepatitis C virus gen

✍ Salvatore Petta; Antonio Craxì 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Meta-analysis: the outcome of anti-viral

✍ A. ANDRIULLI; A. MANGIA; A. IACOBELLIS; A. IPPOLITO; G. LEANDRO; S. ZEUZEM 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Combined antiviral therapy of hepatitis

✍ F. Fabrizi; V. Dixit; P. Martin; P. Messa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Predictors for dose reduction of antivir

✍ Zhou, H.; Luo, H.; Xiao, S.; Wang, H.; Gong, G. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 209 KB

The influence of hepatitis B virus on an

✍ Jun-Ying Liu, Yun-Jian Sheng, Huai-Dong Hu, Qing Zhong, Jing Wang, Shi-Wen Tong, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 277 KB

Outcome of antiviral therapy in Egyptian

✍ Ahmed A. El Khattib; Sara M. Abdelhakam; Dalia M. Ghoraba; Wesam A. Ibrahim; Moa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 112 KB